AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 59 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,157,000 | -51.7% | 176,683 | -51.1% | 0.02% | -51.1% |
| Q2 2021 | $2,397,000 | +22.7% | 360,955 | +5.9% | 0.04% | +9.8% |
| Q1 2021 | $1,954,000 | -53.1% | 340,947 | -26.8% | 0.04% | -55.9% |
| Q4 2020 | $4,164,000 | -39.8% | 465,795 | -21.6% | 0.09% | -60.4% |
| Q3 2020 | $6,913,000 | +30.4% | 593,867 | +79.6% | 0.24% | +22.4% |
| Q2 2020 | $5,302,000 | +193.4% | 330,747 | +9.6% | 0.19% | +97.9% |
| Q1 2020 | $1,807,000 | -55.1% | 301,725 | -1.1% | 0.10% | -47.6% |
| Q4 2019 | $4,028,000 | +6.5% | 305,158 | +0.2% | 0.18% | -11.1% |
| Q3 2019 | $3,783,000 | -14.8% | 304,615 | +10.4% | 0.21% | -5.0% |
| Q2 2019 | $4,441,000 | +56.7% | 275,821 | +206.3% | 0.22% | +44.1% |
| Q1 2019 | $2,834,000 | -10.5% | 90,043 | -6.6% | 0.15% | -32.1% |
| Q4 2018 | $3,167,000 | +2.5% | 96,450 | -4.3% | 0.22% | +33.3% |
| Q3 2018 | $3,090,000 | +18.4% | 100,762 | +3.4% | 0.17% | +7.0% |
| Q2 2018 | $2,610,000 | – | 97,415 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,530,657 | $23,126,000 | 1.85% |
| TFG Asset Management GP Ltd | 2,500,000 | $16,375,000 | 1.00% |
| Nantahala Capital Management | 2,936,791 | $19,236,000 | 0.61% |
| MYDA Advisors LLC | 171,953 | $1,126,000 | 0.32% |
| SABBY MANAGEMENT, LLC | 300,000 | $1,965,000 | 0.27% |
| Regency Capital Management Inc.\DE | 57,000 | $373,000 | 0.26% |
| Ikarian Capital, LLC | 544,819 | $3,568,000 | 0.25% |
| Eversept Partners, LP | 398,074 | $2,607,385 | 0.18% |
| Henry James International Management Inc. | 54,047 | $354,000 | 0.11% |
| Alphabet Inc. | 698,262 | $4,574,000 | 0.11% |